The primary purpose of this research is to assess the benefit on glycemic control, using real time continuous glucose (CGM) versus self monitored blood glucose (SMBG/finger sticks), in persons with Type 2 Diabetes (T2D) taking basal insulin (long-acting) with or without oral medications and/or GLP-1 analogue, not at their HbA1c goal. Secondary objectives are to assess quality of life benefits of RT-CGM and to assess frequency of hypoglycemia. The Phase 2 primary objective is to determine if glycemic control worsens upon withdrawal of RT-CGM. Secondary objectives are to determine if glycemic benefits of RT-CGM use are sustainable for a long period of time (14 months), to assess QoL benefits of continuing or discontinuing RT-CGM, and to assess frequency of hypoglycemia.
Thank you for your interest, but this study is not currently enrolling.
North Carolina (Statewide)